Labs / ADME, DMPK & toxicology
Vectus Biosystems
Rosebery, Australia · vectusbiosystems.com.au
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Vectus Biosystems is a clinical-stage biotechnology company developing small-molecule antifibrotic therapies. It focuses on idiopathic pulmonary fibrosis and broader cardiovascular, renal, and hepatic fibrosis programs. The company is based in Rosebery, New South Wales, Australia.
They take quote requests by email.
What they offer
Antifibrotic drug development
Develops novel small-molecule therapies designed to reverse established fibrotic disease.
Lead program VB0004 development
Advances VB0004, a VIP mimetic and NPR-C agonist, toward clinical evaluation in idiopathic pulmonary fibrosis.
Preclinical antifibrotic research
Works on preclinical antifibrotic assets targeting fibrosis in multiple organs.
What they work on
- Modalities
- Small molecule, Peptide
- Therapeutic areas
- fibrosis, idiopathic pulmonary fibrosis, cardiovascular fibrosis, renal fibrosis, hepatic fibrosis, hypertension
- Address
- 34 Dunning Avenue Rosebery NSW 2018 Australia
- Founded
- 2005
Similar labs. ACM Global Laboratories, Amide Technologies, Analytical Services International, APIGENEX s.r.o.
Found in a contract services directory. Listing built from vectusbiosystems.com.au. Work here? Claim this listing.